CVE-2015-3965
CVE-2015-3965 Vulnerability Analysis & Exploit Intelligence
Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger "unanticipated operations" by leveraging "elevated privileges" for an unspecified call to an incorrectly exposed function.
Published Updated Sources: cvelistV5, icscert
Triage
Is it exploited, how likely is exploitation, what does it touch, and how severe do the scoring sources call it.
Exploitation
Unreported
no source claims exploitation
EPSS
3%
chance of exploitation in 30 days
CVSS base
Unscored
no source published a base score
Affected scope
The catalog records vendors and products as separate lists, not pairs, so which product belongs to which vendor is not something this page can say.
Vendors (1)
Products (1)
References
1 on the record
- ics-cert.us-cert.gov/advisories/ICSA-15-174-01
x_refsource_MISC
Elsewhere on this site
- hospiraevery CVE for this vendor
Not in any source we poll
Listed rather than left blank: an empty field and an unmeasured one look identical on screen, and only one is a reason to look elsewhere.
- No confirmed IOCs, IP addresses, domains, file hashes, or malware artifacts supplied.
- No organization-specific asset inventory, compensating-control status, or patch deployment evidence supplied.
- No exploit packet captures, log samples, or incident case IDs supplied.